Patents/Assignees

OPNA BIO SA

4 patents in portfolio

US12202818utility2025
Compounds and Methods for CD73 Modulation and Indications Therefor
0 cites
US12116365utility2024
Heterocyclic Compounds and Uses Thereof
0 cites
US11807626utility2023
Compounds and Methods for CD73 Modulation and Indications Therefor
0 cites
US11628176utility2023
Combinational Drug Therapies
0 cites